Pelvic floor muscle training in the treatment of lower urinary tract dysfunction in women with multiple sclerosis

Lúcio, Adélia Correia; Campos, Renata Martins; Perissinotto, Maria Carolina Ramos; Miyaoka, Ricardo; Damasceno, Benito Pereira; D’Ancona, Carlos Arturo Levi

doi:10.1002/nau.20941

Cited by 61 publications

(61 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It has also shown positive effects on LUTS in women with neurological diseases (De Ridder, Vermeulen, Ketelaer, Van Poppel, & Baert, 1999;Lucio, D'Ancona, Lopes, Perissinotto, & Damasceno, 2014;Lucio et al, 2010;McClurg, Ashe, Marshall, & Lowe-Strong, 2006;Tibaek, Gard, & Jensen, 2005). In women with urinary incontinence (UI) after a first stroke, 12 weeks of PFMT lead to significant reduction of UI leakage and frequency of daytime voiding while pelvic floor muscle (PFM) function increased significantly (Tibaek et al, 2005).…”

Section: Introductionmentioning

confidence: 99%

Is Pelvic Floor Muscle Training Effective for Men With Poststroke Lower Urinary Tract Symptoms? A Single-Blinded Randomized, Controlled Trial

et al. 2015

View full text Add to dashboard Cite

The aim of the current study was to evaluate the effect of pelvic floor muscle training in men with poststroke lower urinary tract symptoms. Thirty-one poststroke men, median age 68 years, were included in this single-blinded randomized controlled trial. Thirty participants, 15 in each group, completed the study. The intervention consisted of 3 months (12 weekly sessions) of pelvic floor muscle training in groups and home exercises. The effect was evaluated by the DAN-PSS-1 (Danish Prostate Symptom Score) questionnaire, a voiding diary, and digital anal palpation of the pelvic floor muscle. The DAN-PSS-1, symptom score indicated a statistical significant improvement (p < .01) in the treatment group from pretest to posttest, but not in the control group. The DAN-PSS-1, total score improved statistically significantly in both groups from pretest to posttest (treatment group: p < .01; control group: p = .03). The median voiding frequency per 24 hours decreased from 11 at pretest to 7 (36%; p = .04) at posttest and to 8 (27%; p = .02) at follow-up in treatment group, although not statistical significantly more than the control group. The treatment group but not the control group improved statistically significantly in pelvic floor muscle function (p < .01) and strength (p < .01) from pretest to posttest and from pretest to follow-up (p = .03; p < .01). Compared with the control group the pretest to posttest was significantly better in the treatment group (p = .03). The results indicate that pelvic floor muscle training has an effect for lower urinary tract symptoms, although statistical significance was only seen for pelvic floor muscle.

show abstract

Section: Introductionmentioning

confidence: 99%

Is Pelvic Floor Muscle Training Effective for Men With Poststroke Lower Urinary Tract Symptoms? A Single-Blinded Randomized, Controlled Trial

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Investigators found that the PFMT group showed significant reduction of incontinence, nocturia and all domains of the PERFECT scheme evaluation (muscle power, endurance, resistance and fast contraction). There was no significant difference between groups in EDSS, urodynamics, voided volume, 24-h production of urine and daytime urinary frequency [19].…”

Section: Neurogenic Bladder Managementmentioning

confidence: 67%

“…LUTD includes detrusor hyperactivity (urgency, frequency, urge incontinence), detrusor sphincter dyssynergia and detrusor insufficiency (residual urine, incomplete emptying, hesitancy, interrupted stream). Bladder rehabilitation can help reduce urinary leakage and nocturia and may improve QOL [19,20 ]. In a 12-week study, 27 women with MS were blindly randomized to either pelvic floor muscle training (PFMT) with assistance of a vaginal perineometer, or sham training accompanied by use of the perineometer.…”

Section: Neurogenic Bladder Managementmentioning

confidence: 99%

Functional treatments in multiple sclerosis

Courtney

Castro-Borrero

Davis

et al. 2011

Current Opinion in Neurology

View full text Add to dashboard Cite

show abstract

“…5 Several authors have demonstrated the positive influence of PFMT on disease course. [6][7][8][9] However, it is difficult to make general treatment recommendations based on these reports, as they only discuss low-volume, gender-specific methods of outcome assessment. For now, behavioural treatment is indicated only in a minority of patients with mild disability, OAB symptoms, and intact neural pathways to the pelvic floor.…”

Section: Behavioural/physical Treatmentmentioning

confidence: 99%

Treatment of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines

Aharony

Lam

Corcos

2017

CUAJ

View full text Add to dashboard Cite

Multiple sclerosis (MS) is a unique neurological disease with a broad spectrum of clinical presentations that are time-and disease course-related. Lower urinary tract symptoms (LUTS) are highly prevalent in this patient population, with approximately 90% showing some degree of voiding dysfunction and/or incontinence 6-8 years after the initial MS diagnosis. Major therapeutic goals include quality of life improvement and the avoidance of urological complicationsOwing to the wide divergence of clinical symptoms and disease course, evaluation and treatment differ between patients. Treatment must be customized for each patient based on disease phase, patient independence, manual dexterity, social support, and other medical-or MS-related issues. Ablative or irreversible therapies are indicated only when the disease course is stable. In most cases of "safe" bladder, behavioural treatment is considered first-line defense. Antimuscarinic drugs, alone or in combination with intermittent self-catheterization, are currently the mainstay of conservative treatment, and several other medications may help in specific disease conditions. Second-line treatment includes botulinum toxin A injection, neuromodulation, indwelling catheters, and surgery in well-selected cases.

show abstract

Pelvic floor muscle training in the treatment of lower urinary tract dysfunction in women with multiple sclerosis

Abstract: PFMT is an effective approach to treat LUTD in female with MS.

Cited by 61 publications

References 22 publications

Is Pelvic Floor Muscle Training Effective for Men With Poststroke Lower Urinary Tract Symptoms? A Single-Blinded Randomized, Controlled Trial

Is Pelvic Floor Muscle Training Effective for Men With Poststroke Lower Urinary Tract Symptoms? A Single-Blinded Randomized, Controlled Trial

Functional treatments in multiple sclerosis

Treatment of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines

Contact Info

Product

Resources

About